Dr. Marc Eugene Lenaerts, MD

Dr. Lenaerts practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Lenaerts' NPI, 1780652586, was assigned on March 9, 2006. Dr. Lenaerts graduated from Universite de L'Etat a Liege Faculty of Medicine in 1989. Dr. Lenaerts holds California license C 53356.

Dr. Lenaerts' primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Lenaerts' primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Lenaerts to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lenaerts practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lenaerts' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Lenaerts' licenses on file in 3 states: California, Massachusetts and Oklahoma.

Dmand AI lists acute mini-stroke (TIA), encephalopathy, epilepsy, fibromyalgia and chronic pain, head injury, lower back pain, migraine and chronic headache and neuropathy among the conditions Dr. Lenaerts treats.

CMS data shows 640 Medicare services from Dr. Lenaerts across 13 procedure codes in 2024, for 322 Medicare patients. Medicare paid $38,432 for them.

CMS counts 322 Medicare patients who saw Dr. Lenaerts in 2024. The largest group is 65 to 74, with 131 patients. 72% of them have high cholesterol, and 59% have arthritis. 34% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lenaerts' median patient age at 50, with 79% women.

In 2024, Dr. Lenaerts wrote 2,129 Medicare Part D claims for 320 patients. 69% of them were for generic drugs. CMS names the drug for 1,866 of them, across 45 drugs with 11 or more claims each, at $696,911 in total drug cost. In 2023, CMS named 1,685 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lenaerts for performance year 2024, reported as part of a group. Dr. Lenaerts accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lenaerts as offering telehealth. CMS counts 26 procedures of skin biopsy by Dr. Lenaerts, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Lenaerts, published from 2008 to 2019. The most frequent topics are Headache Disorders and Tension-Type Headache. Dr. Lenaerts has published most often in Curr Treat Options Neurol. Dr. Lenaerts' most frequent co-authors are Charles John De Mesa, DO, Randolph Warren Evans, MD and Amy Antman Gelfand, MD.

CMS Open Payments shows 506 general payments to Dr. Lenaerts from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $104,514.

Dr. Lenaerts graduated from Universite de L'Etat a Liege Faculty of Medicine in 1989.

Dr. Lenaerts is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.